Composite Tissue Transplantation
Email this
Print this
Charles W. Hewitt
List price: $159.00 |
|
Table of contentsThe first limb transplant experiments with cyclosporine Relative antigenicity of limb allograft components and differential rejection Induction of transplantation tolerance in large animal models without long term suppression: strategies to manipulate the immune system of the fetal and adult recipient Dendritic cells and alloimmune chimerism in limb transplantation Composite tissue/vascularized bone marrow transplantation: development of donor-host immune chimerism and tolerance Vascularized bone marrow transplantation: pathology of composite tissue transplantation-induced tissue allografts Composite tissue transplantation in rats: a whole limb/hemipelvis model Transplantation of the peripheral nerve allograft Peripheral nerve allotransplants immunosuppressed with 15-deoxuspergualin Therapeutic uses of muscle and factors controlling the efficiency of whole muscle graft regeneration Myoblast transfer as a platform technology of gene therapy and tissue engineering Meniscal allograft transplantation Potential new immunosuppressants for composite tissue transplantation Rationale for local immunosuppression in composite tissue allografting Long term limb and nerve allograft survival with FK506 immunosuppression Allogeneic rat hindlimb transplants immunosuppressed with mycophenolate mofetil (RS-61443) Long term prevention of rejection and combination drug therapy Efficacy of rapamycin and FK506 in prolonging rat hindlimb allograft survival Allogeneic vascularized transplantation of human knee joints Clinical transplantation of skin using immunosuppression The clinical future of composite tissue transplantation Conclusion |
|